Skip to content

Clinical trials

Hepatitis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: Italy Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20092
20123
20132
20151
20223
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
GlaxoSmithKline2
Vir Biotechnology, Inc.2
AusperBio Therapeutics Inc.1
Debiopharm International SA1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Federico II University1
Human Genome Sciences Inc.1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis17
Hepatitis B, Chronic6
Hepatitis B5
Hepatitis, Chronic5
Liver Diseases5
Digestive System Diseases4
Hepatitis C4
Hepatitis C, Chronic4
Hepatitis, Viral, Human3
Virus Diseases3

Trials

Showing 51 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.